AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Cibus Inc. has outlined a $200M annual rice royalty target while advancing its global commercialization strategy. The company is focusing on high-value near-term revenue opportunities in gene-edited traits, particularly in weed management for rice. Management highlighted significant commercialization momentum and validated their decision to prioritize these opportunities.

Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet